Global Markets for Allergy Diagnostics and Treatments

Description

List of Tables

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

The North American market for allergy diagnostics and treatment is projected to grow from $39.7 billion in 2025 to $56.7 billion by the end of 2030, at a CAGR of 7.4% from 2025 through 2030.

The Asia-Pacific market for allergy diagnostics and treatment is projected to grow from $8.6 billion in 2025 to $12.9 billion by the end of 2030, at a CAGR of 8.6% from 2025 through 2030.

Report Scope

This report will provide detailed information on allergy diagnostics and treatments. It analyzes the market trends, with the base year for the study being 2024. It provides estimates for 2025, and forecasts for 2025 through 2030, including the compound annual growth rate (CAGR) for the forecast period. It also analyzes regional markets. This report will highlight allergy diagnostics, current and future market potential of treatments, and a detailed competitive environment analysis. The report will cover regulatory scenarios, drivers, restraints, and opportunities. Also included will be market shares for key players.

The market is segmented into two major categories: diagnostics and treatments. Diagnostics include skin testing (prick, patch, intradermal) and blood testing (antibody). Treatments include antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. Immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The treatments market is segmented into food, drug, inhaled, and others based on allergen type. Drug types are market segmented into prescription drug and over-the-counter (OTC).

The allergy diagnostics and treatment market has been segmented into North America, Europe, the Asia-Pacific, the Middle East and Africa (MEA), and South America. The detailed regional analysis will cover major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided with 2024 as the base year.

Report Includes

161 data tables and 54 additional tables
Analyses of the trends in global markets for allergy diagnostics, immunotherapy and treatments, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the size and revenue prospects for the global market, along with a market share analysis by type, diagnostic type, treatment type, allergen type, drug type, route of administration, and region
Facts and figures pertaining to the market dynamics, new developments in diagnostic testing, advances in treatments, new regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain analyses
Evaluation of recent patent activity and key granted and published patents
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
Profiles of leading companies, including ALK-Abello A/S, Stallergenes Greer, GSK plc., AbbVie Inc., and AstraZeneca

Product Code: PHM026D

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Macroeconomic Factor Analysis
Increasing Healthcare Expenditure
Environmental Pollution and Climate Change
Economic Development and Urbanization
Porter's Five Forces Analysis in the Allergy Diagnostics and Treatment Market
Threat of New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (High)
Threat of Substitutes (High)
Industry Rivalry (High)

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Advances in Allergy Diagnostics and Treatment
Increasing Cases of Allergies Worldwide
Market Restraints
Lack of Skilled Physicians
Side-effects of Allergy Medications
Market Opportunities
Robust Pipeline of Allergy Medications
Personalized Allergy Management via Advanced Biomarker Profiling

Chapter 4 Regulatory Landscape

Overview
Regulatory Framework
U.S.
Europe
Germany
Japan

Chapter 5 Emerging Technologies

Overview
AI-driven Allergy Testing
Datasets Management in Molecular Allergy
Pipeline Analysis
Patent Analysis
Key Findings

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Global Allergy Diagnostics and Treatment Market, by Type
Key Takeaways
Diagnostics
Treatments
Global Allergy Diagnostics and Treatment Market, by Allergen Type
Key Takeaways
Food Allergens
Inhaled Allergens
Drug Allergens
Other Allergens
Global Allergy Diagnostics and Treatment Market, by Drug Type
Key Takeaways
Prescription Drugs
Over-the-Counter Drugs
Market for Drugs, by Route of Administration
Geographic Breakdown
Global Allergy Diagnostics and Treatment Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America

Chapter 7 Competitive Intelligence

Key Takeaways
Company Analysis of the Allergy Diagnostics and Treatment Market

Recent Developments

Recent Product Launches

Chapter 8 Sustainability in the Allergy Diagnostics and Treatment Market: ESG Perspective

Introduction to ESG
Role of ESG in the Allergy Diagnostics and Treatment Market
ESG Risk Ratings
Conclusion

Chapter 9 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBVIE INC.
ALK
AMGEN INC.
ASTRAZENECA
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
GSK PLC.
LILLY
NOVARTIS AG
PFIZER INC.
REVVITY
SANOFI
STALLERGENES GREER
THERMO FISHER SCIENTIFIC INC.
VIATRIS INC.
Emerging Start-ups/Market Disruptors

Product Code: PHM026D

List of Tables

Summary Table : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 1 : Recent Clinical Drug Trials
Table 2 : Difference in the U.S. and European Regulatory Landscapes
Table 3 : Examples of Clinical Trials in Allergy Drug Development
Table 4 : Allergy Diagnostics and Treatments Patent Analysis, 2025
Table 5 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 6 : Global Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 7 : Global Market for Allergy Diagnostics, by Region, Through 2030
Table 8 : Global Market for Allergy Treatment, by Treatment Type, Through 2030
Table 9 : Global Market for Allergy Treatment, by Immunotherapy Type, Through 2030
Table 10 : Global Market for Other Allergy Treatments, by Region, Through 2030
Table 11 : Global Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 12 : Global Market for Food Allergen in Allergy Diagnostic and Treatment, by Region, Through 2030
Table 13 : Global Market for Inhaled Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
Table 14 : Global Market for Drug Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
Table 15 : Global Market for Other Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
Table 16 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 17 : Global Market for Prescription Drugs in Allergy Diagnostics and Treatment, by Region, Through 2030
Table 18 : Global Market for OTC Drugs in Allergy Diagnostics and Treatment, by Region, Through 2030
Table 19 : Advantages and Disadvantages of Drug Routes
Table 20 : Global Market for Allergy Drugs, by Route of Administration, Through 2030
Table 21 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 22 : North American Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 23 : North American Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 24 : North American Market for Allergy Treatment, by Treatment Type, Through 2030
Table 25 : North American Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 26 : North American Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 27 : North American Market for Allergy Diagnostics and Treatment, by Country, Through 2030
Table 28 : U.S. Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 29 : U.S. Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 30 : U.S. Market for Allergy Treatment, by Treatment Type, Through 2030
Table 31 : U.S. Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 32 : U.S. Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 33 : Canadian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 34 : Canadian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 35 : Canadian Market for Allergy Treatment, by Treatment Type, Through 2030
Table 36 : Canadian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 37 : Canadian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 38 : Mexican Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 39 : Mexican Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 40 : Mexican Market for Allergy Treatment, by Treatment Type, Through 2030
Table 41 : Mexican Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 42 : Mexican Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 43 : European Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 44 : European Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 45 : European Market for Allergy Treatment, by Treatment Type, Through 2030
Table 46 : European Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 47 : European Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 48 : European Market for Allergy Diagnostics and Treatment, by Country, Through 2030
Table 49 : German Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 50 : German Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 51 : German Market for Allergy Treatment, by Treatment Type, Through 2030
Table 52 : German Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
Table 53 : German Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 54 : U.K. Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 55 : U.K. Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 56 : U.K. Market for Allergy Treatment, by Treatment Type, Through 2030
Table 57 : U.K. Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 58 : U.K. Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 59 : French Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 60 : French Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 61 : French Market for Allergy Treatment, by Treatment Type, Through 2030
Table 62 : French Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
Table 63 : French Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 64 : Italian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 65 : Italian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 66 : Italian Market for Allergy Treatment, by Treatment Type, Through 2030
Table 67 : Italian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 68 : Italian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 69 : Spanish Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 70 : Spanish Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 71 : Spanish Market for Allergy Treatment, by Treatment Type, Through 2030
Table 72 : Spanish Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 73 : Spanish Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 74 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 75 : Rest of Europe Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 76 : Rest of Europe Market for Allergy Treatment, by Treatment Type, Through 2030
Table 77 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 78 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 79 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 80 : Asia-Pacific Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 81 : Asia-Pacific Market for Allergy Treatment, by Treatment Type, Through 2030
Table 82 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 83 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 84 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Country, Through 2030
Table 85 : Chinese Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 86 : Chinese Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 87 : Chinese Market for Allergy Treatment, by Treatment Type, Through 2030
Table 88 : Chinese Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
Table 89 : Chinese Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 90 : Japanese Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 91 : Japanese Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 92 : Japanese Market for Allergy Treatment, by Treatment Type, Through 2030
Table 93 : Japanese Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 94 : Japanese Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 95 : Indian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 96 : Indian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 97 : Indian Market for Allergy Treatment, by Treatment Type, Through 2030
Table 98 : Indian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 99 : Indian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 100 : South Korean Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 101 : South Korean Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 102 : South Korean Market for Allergy Treatment, by Treatment Type, Through 2030
Table 103 : South Korean Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 104 : South Korean Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 105 : Australian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 106 : Australian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 107 : Australian Market for Allergy Treatment, by Treatment Type, Through 2030
Table 108 : Australian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 109 : Australian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 110 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 111 : Rest of Asia-Pacific Market for Allergy Diagnostics, by Type, Through 2030
Table 112 : Rest of Asia-Pacific Market for Allergy Treatment, by Type, Through 2030
Table 113 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 114 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 115 : MEA Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 116 : MEA Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 117 : MEA Market for Allergy Treatment, by Treatment Type, Through 2030
Table 118 : MEA Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 119 : MEA Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 120 : MEA Market for Allergy Diagnostics and Treatment, by Sub-region, Through 2030
Table 121 : Middle East Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 122 : Middle East Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 123 : Middle East Market for Allergy Treatment, by Treatment Type, Through 2030
Table 124 : Middle East Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 125 : Middle East Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 126 : African Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 127 : African Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 128 : African Market for Allergy Treatment, by Treatment Type, Through 2030
Table 129 : African Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 130 : African Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 131 : South American Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 132 : South American Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 133 : South American Market for Allergy Treatment, by Treatment Type, Through 2030
Table 134 : South American Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 135 : South American Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 136 : South American Market for Allergy Diagnostics and Treatment, by Country, Through 2030
Table 137 : Brazilian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 138 : Brazilian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 139 : Brazilian Market for Allergy Treatment, by Treatment Type, Through 2030
Table 140 : Brazilian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 141 : Brazilian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 142 : Argentine Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 143 : Argentine Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 144 : Argentine Market for Allergy Treatment, by Treatment Type, Through 2030
Table 145 : Argentine Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 146 : Argentine Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 147 : Rest of South America Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 148 : Rest of South America Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
Table 149 : Rest of South America Market for Allergy Treatment, by Treatment Type, Through 2030
Table 150 : Rest of South America Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
Table 151 : Rest of South America Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 152 : Leading Companies, 2024
Table 153 : Recent Developments in the Global Allergy Diagnostics and Treatment Market, 2022-2024
Table 154 : Product Launches in Allergy Diagnostics and Treatment Market, 2022-2025
Table 155 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
Table 156 : Report Information Sources
Table 157 : Abbreviations Used in the Allergy Diagnostics and Treatment Market
Table 158 : AbbVie Inc.: Company Snapshot
Table 159 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 160 : AbbVie Inc.: Product Portfolio
Table 161 : AbbVie Inc.: News/Key Developments, 2025
Table 162 : ALK: Company Snapshot
Table 163 : ALK: Financial Performance, FY 2023 and 2024
Table 164 : ALK: Product Portfolio
Table 165 : ALK: News/Key Developments, 2025
Table 166 : Amgen Inc.: Company Snapshot
Table 167 : Amgen Inc.: Financial Performance, FY 2023 and 2024
Table 168 : Amgen Inc.: Product Portfolio
Table 169 : Amgen Inc.: News/Key Developments, 2023
Table 170 : AstraZeneca: Company Snapshot
Table 171 : AstraZeneca: Financial Performance, FY 2023 and 2024
Table 172 : AstraZeneca: Product Portfolio
Table 173 : AstraZeneca: News/Recent Developments, 2023
Table 174 : Bayer AG: Company Snapshot
Table 175 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 176 : Bayer AG: Product Portfolio
Table 177 : Bayer AG: News/Key Development, 2022
Table 178 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 179 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 180 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 181 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024 and 2025
Table 182 : GSK plc.: Company Snapshot
Table 183 : GSK plc.: Financial Performance, FY 2023 and 2024
Table 184 : GSK plc.: Product Portfolio
Table 185 : GSK plc.: News/Key Developments, 2024
Table 186 : Lilly: Company Snapshot
Table 187 : Lilly: Financial Performance, FY 2023 and 2024
Table 188 : Lilly: Product Portfolio
Table 189 : Lilly: News/Key Developments, 2024
Table 190 : Novartis AG: Company Snapshot
Table 191 : Novartis AG: Financial Performance, FY 2023 and 2024
Table 192 : Novartis AG: Product Portfolio
Table 193 : Novartis AG: News/Key Developments 2024
Table 194 : Pfizer Inc.: Company Snapshot
Table 195 : Pfizer Inc.: Financial Performance, FY 2023 and 2024
Table 196 : Pfizer Inc.: Product Portfolio
Table 197 : Pfizer Inc.: News/Key Developments, 2022 and 2023
Table 198 : Revvity: Company Snapshot
Table 199 : Revvity: Financial Performance, FY 2023 and 2024
Table 200 : Revvity: Product Portfolio
Table 201 : Sanofi: Company Snapshot
Table 202 : Sanofi: Financial Performance, FY 2023 and 2024
Table 203 : Sanofi: Product Portfolio
Table 204 : Stallergenes Greer: Company Snapshot
Table 205 : Stallergenes Greer: Product Portfolio
Table 206 : Stallergenes Greer: News/Key Developments, 2024 and 2025
Table 207 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 208 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 209 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 210 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
Table 211 : Viatris Inc.: Company Snapshot
Table 212 : Viatris Inc.: Financial Performance, FY 2023 and 2024
Table 213 : Viatris Inc.: Product Portfolio
Table 214 : List of Few Emerging Startups

List of Figures

Summary Figure : Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Allergy Diagnostic and Treatment Market
Figure 2 : Market Dynamics for Allergy Diagnostics and Treatment
Figure 3 : Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 4 : Global Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 5 : Global Market Shares of Allergy Diagnostics, by Region, 2024
Figure 6 : Global Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 7 : Global Market Shares of Allergy Treatment, by Immunotherapy Type, 2024
Figure 8 : Global Market Shares of Allergy Treatment, by Region, 2024
Figure 9 : Global Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 10 : Global Market Shares for Food Allergens in Allergy Diagnostics and Treatment, by Region, 2024
Figure 11 : Global Market Shares for Inhaled Allergens in Allergy Diagnostics and Treatment, by Region, 2024
Figure 12 : Global Market Shares of Drug Allergens in Allergy Diagnostics and Treatment, by Region, 2024
Figure 13 : Global Market Shares of Other Allergens in Allergy Diagnostics and Treatment, by Region, 2024
Figure 14 : Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 15 : Global Market Shares of Prescription Drugs in Allergy Diagnostics and Treatment, by Region, 2024
Figure 16 : Global Market Shares of OTC Drugs in Allergy Diagnostics and Treatment, by Region, 2024
Figure 17 : Global Market Shares of Allergy Drugs, by Route of Administration, 2024
Figure 18 : Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
Figure 19 : North American Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 20 : North American Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 21 : North American Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 22 : North American Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 23 : North American Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 24 : North American Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
Figure 25 : European Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 26 : European Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 27 : European Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 28 : European Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 29 : European Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 30 : European Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
Figure 31 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 32 : Asia-Pacific Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 33 : Asia-Pacific Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 34 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 35 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 36 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
Figure 37 : Indian Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 38 : MEA Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 39 : MEA Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 40 : MEA Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 41 : MEA Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 42 : MEA Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 43 : MEA Market Shares of Allergy Diagnostics and Treatment, by Sub-region, 2024
Figure 44 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 45 : Middle East Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 46 : Middle East Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 47 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 48 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 49 : African Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 50 : African Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 51 : African Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 52 : African Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 53 : African Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 54 : South American Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 55 : South American Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
Figure 56 : South American Market Shares of Allergy Treatment, by Treatment Type, 2024
Figure 57 : South American Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
Figure 58 : South American Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 59 : South American Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
Figure 60 : Pillars of ESG
Figure 61 : Advantages of ESG for Companies
Figure 62 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
Figure 63 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
Figure 64 : ALK: Revenue Share, by Business Unit, FY 2024
Figure 65 : ALK: Revenue Share, by Country/Region, FY 2024
Figure 66 : Amgen Inc.: Revenue Share, by Business Unit, FY 2024
Figure 67 : Amgen Inc.: Revenue Share, by Country/Region, FY 2024
Figure 68 : AstraZeneca: Revenue Share, by Business Unit, FY 2024
Figure 69 : AstraZeneca: Revenue Share, by Region/Country, FY 2024
Figure 70 : Bayer AG: Revenue Share, by Business Unit, FY 2024
Figure 71 : Bayer AG: Revenue Share, by Country/Region, FY 2024
Figure 72 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 73 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 74 : GSK plc.: Revenue Share, by Business Unit, FY 2024
Figure 75 : GSK plc.: Revenue Share, by Country/Region, FY 2024
Figure 76 : Lilly: Revenue Share, by Business Unit, FY 2024
Figure 77 : Lilly: Revenue Share, by Country/Region, FY 2024
Figure 78 : Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 79 : Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 80 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2024
Figure 81 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2024
Figure 82 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 83 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 84 : Sanofi: Revenue Share, by Business Unit, FY 2024
Figure 85 : Sanofi: Revenue Share, by Country/Region, FY 2024
Figure 86 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 87 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
Figure 88 : Viatris Inc.: Revenue Share, by Business Unit, FY 2024
Figure 89 : Viatris Inc.: Revenue Share, by Country/Region, FY 2024

Global Markets for Allergy Diagnostics and Treatments

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in the Allergy Diagnostics and Treatment Market: ESG Perspective

Chapter 9 Appendix

List of Tables

List of Figures